Manufacturing

Margaret (Peggy) Marino, PhD, is senior vice-president, Program Management, at AnaptysBio.

Articles

It is critical to evaluate specific considerations, from design to application, for the benefit of downstream bioprocessing and manufacturing.

Points to Consider for Continuous Downstream Bioprocessing

Agnes Shanley is senior editor of Pharmaceutical Technology.

Better understanding and control of cell behavior is yielding benefits, upstream and beyond. 


Improving Upstream Predictability

GE Healthcare Life Sciences’ KUBio box is an integrated, flexible biomanufacturing environment for viral vector-based gene therapies.

GE Healthcare Launches Viral Vector-Based Gene Therapy Manufacturing

Agnes Shanley is senior editor of BioPharm International.

Used with perfusion, alternating tangential flow and tangential flow filtration are redefining upstream efficiency.


Technology Redefines Continuous Processing Efficiency

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

The evolution of cell-culture technology is driving the need for improvements in modeling solutions.

Cell-Culture Advances Test Bioreactor Performance Models

NIIMBL announced it is partnering with FDA through the University of Delaware to improve biopharmaceutical manufacturing.

NIIMBL and FDA Partner in Biopharmaceutical Manufacturing

Real-time monitoring of product- and process-related impurities remains a challenge.

Analysis of Residual Impurities in Continuous Manufacturing

Although downstream efficiency still lags behind upstream, engineering-driven innovation is breaking through boundaries.

Catching Up Downstream

The learning curve for process analytical technology has slowed widespread adoption. 

Moving PAT from Concept to Reality

Pharmaceutical Technology and BioPharm International will present a Keynote Session on Meeting Bioprocessing Manufacturing Capacity Demands on Wednesday, April 3, 2019, during INTERPHEX 2019 at the Javits Center in New York City.

Biologic Drug Manufacturing Capacity on the Agenda for INTERPHEX 2019 Keynote Series

Educational sessions on the INTERPHEX show floor will include a panel discussion on implementing continuous manufacturing.

INTERPHEX 2019 Keynote Series Presents Panel Discussion on OSD Continuous Manufacturing

3D printing offers a new design freedom for bio/pharmaceutical manufacturing: whether for “printing” a solid-dosage drug or for creating a piece of equipment for bio/pharmaceutical laboratories or manufacturing facilities. 

INTERPHEX 2019 Keynote Series Presents Session on 3D Printing in Pharma

Editor of Pharmaceutical Technology Europe

A look at the Univercells' NevoLine bio manufacturing platform, which incorporates principles of automated and continuous bioprocessing.

Continuous Bioprocessing of Vaccines

NJII and Pall collaborate to address biomanufacturing technology and workforce development challenges.

NJII and Pall Partner on Cell and Gene Therapy Manufacturing Development

A continuous peptide manufacturing process invented by Swedish Biomimetics 3000 Ltd is a platform technology also applicable to other solid-phase chemical processes, such as chromatography.

Continuous Peptide Manufacturing Process is a New Alternative to Batch Manufacturing

GE Healthcare will collaborate with Wego Pharmaceutical in China for local production and supply of GE Healthcare’s Fortem single-use consumables.

GE Healthcare Manufactures Single-Use Consumables in China

The maturation of single-use technologies presents commercial bioprocessing options for small-volume drug products.  

A Plastic Pipeline for Commercial Bioprocessing?

A collaboration using Pall’s bioprocessing technology in G-CON’s PODs enables flexible continuous bioprocessing and viral vector facility solutions.

Pall and G-CON Collaborate on Scalable Turnkey Solutions for Bioprocessing

FDA awarded nearly $3 million in grants for continuous manufacturing and other advanced manufacturing technologies as part of the agency’s efforts to ensure a robust and reliable supply of biological products.

FDA Awards Five Grants for Advanced Biomanufacturing Research

A collaboration integrates Sartorius Stedim Biotech’s BIOSTAT STR bioreactors and Repligen’s XCell ATF cell-retention control technology to create simplified, scalable equipment for intensified cell culture.

Manufacturing, Continuous Biologics Processing